Which is the most valuable treatment for recurrent in-stent restenosis, namely the ISR of 2 already implanted stents? We investigated the role of drug-coated balloons in this setting, and our findings seem to show how this strategy should be considered.
This is the GISE poster. The publication will follow soon.
